Group 1 - The core point of the news is that Haili Biological experienced a stock price increase of 5.08%, reaching 6.41 CNY per share, with a total market capitalization of 4.203 billion CNY as of the report date [1] - Haili Biological, established on July 18, 1981, specializes in the research, production, and sales of animal vaccines, with its main business revenue composition being 71.34% from oral vaccines, 28.61% from IVD, and 0.05% from other sources [1] Group 2 - From the perspective of Haili Biological's top ten circulating shareholders, Guotai Fund's ETF, Guotai Zhongzheng Animal Husbandry ETF (159865), increased its holdings by 3.6987 million shares, totaling 10.2279 million shares, which represents 1.58% of the circulating shares [2] - The Guotai Zhongzheng Animal Husbandry ETF (159865) was established on March 1, 2021, with a current scale of 6.097 billion CNY and has achieved a year-to-date return of 11.41%, ranking 3417 out of 4189 in its category [2]
海利生物股价涨5.08%,国泰基金旗下1只基金位居十大流通股东,持有1022.79万股浮盈赚取317.06万元